The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Hyperhomocysteinemia and Low Pyridoxal Phosphate: Common and Independent Reversible Risk Factors for Coronary Artery Disease
Abstract
Background High plasma homocysteine is associated with premature coronary artery disease in men, but the threshold concentration defining this risk and its importance in women and the elderly are unknown. Furthermore, although low B vitamin status increases homocysteine, the link between these vitamins and coronary disease is unclear. Methods and Results We compared 304 patients with coronary disease with 231 control subjects. Risk factors and concentrations of plasma homocysteine, folate, vitamin B12, and pyridoxal 5′-phosphate were documented. A homocysteine concentration of 14 μmol/L conferred an odds ratio of coronary disease of 4.8 ( P <.001), and 5-μmol/L increments across the range of homocysteine conferred an odds ratio of 2.4 ( P <.001). Odds ratios of 3.5 in women and of 2.9 in those 65 years or older were seen ( P <.05). Homocysteine correlated negatively with all vitamins. Low pyridoxal 5′-phosphate (<20 nmol/L) was seen in 10% of patients but in only 2% of control subjects ( P <.01), yielding an odds ratio of coronary disease adjusted for all risk factors, including high homocysteine, of 4.3 ( P <.05). Conclusions Within the range currently considered to be normal, the risk for coronary disease rises with increasing plasma homocysteine regardless of age and sex, with no threshold effect. In addition to a link with homocysteine, low pyridoxal-5′-phosphate confers an independent risk for coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Self-citationVitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationA Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Self-citationMudd, S. H. (1989) · Medical Entomology and Zoology · Cited by 1,019
Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification
Goyette, P., Sumner, J. S., Milos, R., Duncan, A. M. V., Rosenblatt, D. S., Matthews, R. G., & Rozen, R. (1994) · Nature Genetics · doi:10.1038/ng0694-195 · Cited by 892
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Kang, S. S., WONG, P. W. K., Susmano, A., Sora, J., Norušis, M. J., & Ruggie, N. (1991) · PubMed · Cited by 600
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Wilcken, D. E., & Wilcken, B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108350 · Cited by 529
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
Malinow, M. R., Kang, S. S., Taylor, L. M., Wong, P. W., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., & Upson, B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1180 · Cited by 501
Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland
Carson, N. A. J., & Neill, D. W. (1962) · Archives of Disease in Childhood · doi:10.1136/adc.37.195.505 · Cited by 491
Stabler, S. P., Marcell, P. D., Podell, E. R., Allen, R. H., Savage, D. G., & Lindenbaum, J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113343 · Cited by 478
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
Ubbink, J., Vermaak, W., van der Merwe, A., & Becker, P. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.1.47 · Cited by 461
Jacobsen, D. W., Gatautis, V. J., Green, R., Robinson, K., Savon, S. R., Secic, M., Ji, J., Otto, J. M., & Taylor, L. M. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.6.873 · Cited by 435
Self-citationBrattström, L., Israelsson, B., Norrving, B., Bergqvist, D., Thörne, J., Hultberg, B., & Hamfelt, A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90058-q · Cited by 389
Pancharuniti, N., Lewis, C., Sauberlich, H., Perkins, L., Go, R., Alvarez, J., Macaluso, M., Acton, R., Copeland, R., Cousins, A., et al. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.940 · Cited by 380
Folic acid—an innocuous means to reduce plasma homocysteine
Brattström, L. E., Israelsson, B., Jeppsson, J.-O., & Hultberg, B. L. (1988) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518809167487 · Cited by 363
Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
Kang, S. S., Wong, P. W., Cook, H. Y., Norusis, M., & Messer, J. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112461 · Cited by 302
Thiazide Diuretic Agents and the Incidence of Hip Fracture
LaCroix, A. Z., Wienpahl, J., White, L. R., Wallace, R. B., Scherr, P. A., George, L. K., Cornoni-Huntley, J., & Ostfeld, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002013220502 · Cited by 299
Plasma homocyst(e)ine levels in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., Wilson, P. W. F., Schaefer, E. J., & Malinow, M. R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90542-w · Cited by 296
Goyette, P., Frosst, P. D., Rosenblatt, D. S., & Rozen, R. R. (1995) · Europe PMC (PubMed Central) · Cited by 261
BRATTSTRÖM, L., LINDGREN, A., ISRAELSSON, B., MALINOW, M. R., NORRVING, B., UPSON, B., & HAMFELT, A. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01829.x · Cited by 257
Taylor, L. M., DeFrang, R. D., Harris, E. J., & Porter, J. M. (1991) · Journal of Vascular Surgery · doi:10.1016/0741-5214(91)90020-u · Cited by 248
Brattström, L., Israelsson, B., Lindgärde, F., & Hultberg, B. (1988) · Metabolism · doi:10.1016/s0026-0495(98)90014-2 · Cited by 221
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease
Wu, L. L., Wu, J., Hunt, S. C., James, B. C., Vincent, G. M., Williams, R. R., & Hopkins, P. N. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.552 · Cited by 179
Treatment of mild hyperhomocysteinemia in vascular disease patients.
Franken, D. G., Boers, G. H., Blom, H. J., Trijbels, F. J., & Kloppenborg, P. W. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.465 · Cited by 178
Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate.
Camp, V. M., Chipponi, J., & Faraj, B. A. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.4.642 · Cited by 112
Radioenzymatic Assay for Direct Measurement of Plasma Pyridoxal 5'-Phosphate
Camp, V. M., Faraj, B. A., & Chipponi, J. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.5.734 · Cited by 107
Pyridoxal 5′-phosphate—A new physiological inhibitor of blood coagulation and platelet function
Subbarao, K., Kuchibhotla, J., & Kakkar, V. V. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90248-x · Cited by 45
Cited by
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Metadata
- Authors
- Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., Kutner, M., Topol, E. J., & Jacobsen, D. W.
- Venue
- Circulation
- Published
- 1995-11-15
- Volume
- 92
- Issue
- 10
- Pages
- 2825-2830
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2156158060
- Cited by
- 390
- References
- 30
- FWCI
- 21.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.